These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 38256166)
1. Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. Waseem M; Wang BD Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256166 [TBL] [Abstract][Full Text] [Related]
2. Engineering prostate cancer in vitro: what does it take? Buskin A; Scott E; Nelson R; Gaughan L; Robson CN; Heer R; Hepburn AC Oncogene; 2023 Aug; 42(32):2417-2427. PubMed ID: 37438470 [TBL] [Abstract][Full Text] [Related]
3. A synopsis of prostate organoid methodologies, applications, and limitations. Gleave AM; Ci X; Lin D; Wang Y Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293 [TBL] [Abstract][Full Text] [Related]
4. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics]. Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525 [TBL] [Abstract][Full Text] [Related]
5. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine. Pamarthy S; Sabaawy HE Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953 [TBL] [Abstract][Full Text] [Related]
6. Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer. Mickova A; Morong M; Levková M; Kurfúrstová D; Kharaishvili G; Überall I; Student V; Student V; Drapela S; Soucek K; Bouchal J Klin Onkol; 2022; 35(6):473-481. PubMed ID: 36513514 [TBL] [Abstract][Full Text] [Related]
8. Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer. Bigot L; Sabio J; Poiraudeau L; Annereau M; Menssouri N; Helissey C; Déas O; Aglave M; Ibrahim T; Pobel C; Nobre C; Nicotra C; Ngo-Camus M; Lacroix L; Rouleau E; Tselikas L; Judde JG; Chauchereau A; Bernard-Tessier A; Patrikidou A; Naoun N; Flippot R; Colomba E; Fuerea A; Albiges L; Lavaud P; Massard C; Friboulet L; Fizazi K; Besse B; Scoazec JY; Loriot Y Eur Urol Oncol; 2024 Jun; 7(3):527-536. PubMed ID: 38433714 [TBL] [Abstract][Full Text] [Related]
9. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens. Servant R; Garioni M; Vlajnic T; Blind M; Pueschel H; Müller DC; Zellweger T; Templeton AJ; Garofoli A; Maletti S; Piscuoglio S; Rubin MA; Seifert H; Rentsch CA; Bubendorf L; Le Magnen C J Pathol; 2021 Aug; 254(5):543-555. PubMed ID: 33934365 [TBL] [Abstract][Full Text] [Related]
10. A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening. Beshiri ML; Tice CM; Tran C; Nguyen HM; Sowalsky AG; Agarwal S; Jansson KH; Yang Q; McGowen KM; Yin J; Alilin AN; Karzai FH; Dahut WL; Corey E; Kelly K Clin Cancer Res; 2018 Sep; 24(17):4332-4345. PubMed ID: 29748182 [No Abstract] [Full Text] [Related]
11. Application of Organoid Models in Prostate Cancer Research. Zhou L; Zhang C; Zhang Y; Shi C Front Oncol; 2021; 11():736431. PubMed ID: 34646778 [TBL] [Abstract][Full Text] [Related]
12. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer. Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y Front Immunol; 2023; 14():1180184. PubMed ID: 37334366 [TBL] [Abstract][Full Text] [Related]
14. Patient-derived organoids as a model for tumor research. Wang J; Feng X; Li Z; Chen Y; Huang W Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351 [TBL] [Abstract][Full Text] [Related]
15. Tumor organoids: applications in cancer modeling and potentials in precision medicine. Xu H; Jiao D; Liu A; Wu K J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634 [TBL] [Abstract][Full Text] [Related]
16. Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research. Elbadawy M; Abugomaa A; Yamawaki H; Usui T; Sasaki K Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32218271 [TBL] [Abstract][Full Text] [Related]
17. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine. Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791 [TBL] [Abstract][Full Text] [Related]
18. Cancer organoid co-culture model system: Novel approach to guide precision medicine. Yuan J; Li X; Yu S Front Immunol; 2022; 13():1061388. PubMed ID: 36713421 [TBL] [Abstract][Full Text] [Related]
19. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges. Li J; Liu J; Xia W; Yang H; Sha W; Chen H Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190 [TBL] [Abstract][Full Text] [Related]
20. Current experimental human tissue-derived models for prostate cancer research. Kato M; Sasaki T; Inoue T Int J Urol; 2021 Feb; 28(2):150-162. PubMed ID: 33247498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]